Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6258
Source ID: NCT00394407
Associated Drug: Sliding Scale Regular Insulin
Title: Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes|Hyperglycemia
Interventions: DRUG: sliding scale regular insulin|DRUG: glargine basal insulin and glulisine prandial insulin
Outcome Measures: Primary: blood glucose control, Differences in BG control will be assessed between the 2 arms acqhs and as needed for those patients hospitalized on the non-medical floors, During hospitalization | Secondary: frequency of hypoglycemia, assess differences in the frequency of hypoglycemia between the 2 study arms, during the hospitalization|frequency of severe hyperglycemia (BG > 400 mg/dl),, evaluate differences in severe hyperglycemia between the 2 study arms, during the hospitalization|length of hospital stay, differences in LOS between study arms, during hospitalization|inflammatory markers, C-reactive protein, interleukin-6, and tumor necrosis factor, during hospitalization
Sponsor/Collaborators: Sponsor: Emory University | Collaborators: Sanofi|University of Miami
Gender: FEMALE
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 130
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2005-09
Completion Date: 2006-06
Results First Posted:
Last Update Posted: 2013-11-21
Locations: University of Miami School of Medicine, Coral Gables, Florida, 33124, United States
URL: https://clinicaltrials.gov/show/NCT00394407